Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Tangible Net Worth Ratio
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Tangible Net Worth Ratio of 90.7% as of June 2026. This metric is calculated by deducting intangible assets (CN¥311.35 Million) from net assets (CN¥3.34 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Fujian Aonong Biological Technology Grou equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Fujian Aonong Biological Technology Group Incorporation Ltd Tangible Net Worth Ratio (2013–2025)
This chart shows how Fujian Aonong Biological Technology Group Incorporation Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 90.7%, reflecting net assets of CN¥3.34 Billion with intangible assets of CN¥311.35 Million CNY. Check 603363 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Tangible Net Worth Ratio for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Fujian Aonong Biological Technology Grou.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 91.2% | CN¥3.58 Billion | CN¥315.96 Million | CN¥8.74 Billion | ▲ +1.9 pp |
| 2024 | 89.3% | CN¥3.06 Billion | CN¥328.81 Million | CN¥9.51 Billion | ▲ +8.2 pp |
| 2022 | 81.0% | CN¥3.43 Billion | CN¥651.20 Million | CN¥18.66 Billion | ▲ +2.1 pp |
| 2021 | 78.9% | CN¥2.19 Billion | CN¥462.70 Million | CN¥17.10 Billion | ▼ -11.5 pp |
| 2020 | 90.4% | CN¥3.90 Billion | CN¥374.46 Million | CN¥12.02 Billion | ▲ +6.5 pp |
| 2019 | 83.9% | CN¥1.28 Billion | CN¥207.06 Million | CN¥4.92 Billion | ▲ +1.4 pp |
| 2018 | 82.5% | CN¥1.01 Billion | CN¥176.95 Million | CN¥3.31 Billion | ▼ -2.7 pp |
| 2017 | 85.2% | CN¥965.55 Million | CN¥143.23 Million | CN¥2.54 Billion | ▲ +1.9 pp |
| 2016 | 83.2% | CN¥593.75 Million | CN¥99.64 Million | CN¥1.71 Billion | ▼ -0.5 pp |
| 2015 | 83.7% | CN¥445.39 Million | CN¥72.49 Million | CN¥1.35 Billion | ▲ +3.9 pp |
| 2014 | 79.8% | CN¥214.94 Million | CN¥43.41 Million | CN¥926.86 Million | ▼ -3.9 pp |
| 2013 | 83.7% | CN¥106.35 Million | CN¥17.29 Million | CN¥710.45 Million | — |